AMX0035, PL1 Oral powder in sachet, oral use
A35-004
Phase 3 small_molecule active
Quick answer
AMX0035, PL1 Oral powder in sachet, oral use for Amyotrophic Lateral Sclerosis (ALS) is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Amyotrophic Lateral Sclerosis (ALS)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active